CPT® Code 80326

Official Description

Amphetamines; 5 or more

Common Language Description

The CPT® Code 80326 refers to a laboratory test specifically designed to measure the presence of five or more amphetamines in various biological samples, including serum, urine, saliva, hair, and stool. Amphetamines are a class of central nervous system stimulants that are primarily utilized in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. This category of drugs encompasses not only traditional amphetamines but also designer drugs such as methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA, commonly known as Ecstasy), and methylenedioxyethylamphetamine (MDEA, referred to as Eve). These designer drugs possess both stimulant and hallucinogenic properties, which can lead to significant abuse and addiction potential. The testing for amphetamines is crucial, as it helps in monitoring drug use and ensuring patient safety. The detection windows for amphetamines vary by sample type: they can be identified in blood or serum for up to 12 hours post-ingestion, in urine for 2 to 5 days, in saliva for 1 to 5 days, and in hair for as long as 90 days. The methodologies employed for testing include high-performance liquid chromatography coupled with tandem mass spectrometry for serum, urine, and stool samples, while hair samples are analyzed using gas chromatography/mass spectrometry. Saliva testing is conducted through a rapid immunochromatographic assay. This code is part of a series where code 80324 is designated for testing 1 or 2 amphetamines, and code 80325 is for 3 or 4 amphetamines, making 80326 the appropriate choice for testing five or more amphetamines.

1. Indications

The laboratory test represented by CPT® Code 80326 is indicated for the detection and quantification of five or more amphetamines in various biological specimens. This test is particularly relevant in the following scenarios:

Monitoring Substance Abuse: The test is utilized to assess potential abuse of amphetamines, including both prescription medications and illicit designer drugs.
Clinical Evaluation: It aids healthcare providers in evaluating patients who may be experiencing symptoms related to amphetamine use or withdrawal.
Legal and Forensic Testing: The test may be employed in legal contexts to determine drug use in individuals involved in legal proceedings or workplace drug testing.
Assessment of Treatment Compliance: It helps in monitoring patients prescribed amphetamines for ADHD or narcolepsy to ensure adherence to their treatment regimen.

2. Procedure

The procedure for conducting the test associated with CPT® Code 80326 involves several key steps to ensure accurate measurement of amphetamines in the specified biological samples. The following procedural steps are typically followed:

Sample Collection: Biological samples such as serum, urine, saliva, hair, or stool are collected from the patient. The choice of sample type may depend on the clinical context and the specific substances being tested.
Sample Preparation: The collected samples undergo preparation, which may include processes such as centrifugation for serum or urine, and appropriate handling techniques for hair and saliva to ensure integrity and prevent contamination.
Analytical Testing: The prepared samples are subjected to high-performance liquid chromatography coupled with tandem mass spectrometry for serum, urine, and stool analysis. Hair samples are analyzed using gas chromatography/mass spectrometry, while saliva is tested using a rapid immunochromatographic assay. These methodologies are chosen for their sensitivity and specificity in detecting amphetamines.
Data Interpretation: The results obtained from the analytical tests are interpreted by qualified laboratory personnel, who assess the presence and concentration of amphetamines in the samples.
Reporting Results: Finally, the findings are compiled into a report that is provided to the requesting healthcare provider, detailing the presence of five or more amphetamines and any relevant quantitative data.

3. Post-Procedure

After the completion of the testing procedure associated with CPT® Code 80326, several post-procedure considerations are important. The results of the amphetamine test can have significant implications for patient management and treatment decisions. Healthcare providers should review the results in conjunction with the patient's clinical history and any presenting symptoms. If amphetamines are detected, further evaluation may be warranted to assess the extent of use and potential implications for treatment. Additionally, patients may require counseling or referral to substance abuse programs if misuse is suspected. It is also essential to maintain proper documentation of the test results and any subsequent actions taken based on those results to ensure compliance with regulatory and clinical guidelines.

Short Descr	AMPHETAMINES 5 OR MORE
Medium Descr	DRUG SCREEN QUANT AMPHETAMINES 5 OR MORE
Long Descr	Amphetamines; 5 or more
Status Code	Not Valid for Medicare Purposes
Global Days	XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC)	9 - Not Applicable
Multiple Procedures (51)	9 - Concept does not apply.
Bilateral Surgery (50)	9 - Concept does not apply.
Physician Supervisions	09 - Concept does not apply.
Assistant Surgeon (80, 82)	9 - Concept does not apply.
Co-Surgeons (62)	9 - Concept does not apply.
Team Surgery (66)	9 - Concept does not apply.
Diagnostic Imaging Family	99 - Concept Does Not Apply
APC Status Indicator	Code Not Recognized by OPPS when submitted on Outpatient Hospital Part B Bill Type (12x/13x)
Type of Service (TOS)	5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS)	T2D - Other tests - other
MUE	1

26	Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
90	Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.